Mathias Frederiksen
Principal @ Novartis Venture Fund
Basel, Basel
Invests in
Sectors:
Locations:
Min Investment:
$5,000,000.00Max Investment:
$10,000,000.00Target Investment:
$7,500,000.00
Skills
Education
- SU
- IC
- MA
- UA
Lists including Mathias
Investments
Work Experience
Principal
2023
Associate
2022 - 2023
Discover and nurture biotech start-ups from seed to IPO.
2024
Board Observer
2024
2023
Director Board of Directors
2023
Helping FMP to realize breakthrough therapies in neurodegeneration
Board Observer
2023
2022
Board Observer
2022
The UZH Life Sciences Fund is a partnership between the UZH Foundation and Novartis Venture Fund to seed UZH spinouts in the field of life sciences.
2022
Board Observer
2022
Helping LOQUS23 amazing team to bring small molecule therapeutics to patients suffering from triplet expansion disorders like Huntington's Disease.
2005 - 2022
Associate Director and Group Leader Chomatin Chemical Biology
2020 - 2022
Directing a research program aimed at elucidating the role of epigenetic regulation in human disease to uncover novel paradigms for chromatin-focused drug discovery.
Senior Investigator II
2018 - 2020
Group leader Chromatin Chemical Biology: Directing a research program aimed at elucidating the role of epigenetic regulation in human disease to uncover novel paradigms for chromatin-focused drug discovery.
Senior Investigator I
2014 - 2018
Lab-head Global Discovery Chemistry - Chemogenetics Chemical proteomics, new target discovery, new chemical technologies at the interface of chemistry and biology.
Investigator III
2010 - 2014
Lab-head Global Discovery Chemistry - Chemogenetics Chemical proteomics, new target discovery, new chemical technologies at the interface of chemistry and biology.
Research Investigator II
2007 - 2009
Lab-head Global Discovery Chemistry - Neuroscience Development of novel therapeutic agents against Neurodegenerative disease.
Research Investigator I
2005 - 2007
Lab-head Global Discovery Chemistry - Neuroscience Development of novel therapeutic agents against Neurodegenerative disease.
2003 - 2004
Post-doctoral Research Investigator
2003 - 2004
Research Fellow in the laboratories of Professor Barry Trost, working on Pd-catalyzed asymmetric alkylation reactions and total synthesis. Funded by GSK Postdoctoral Fellowship
1998 - 2002
PhD Candidate
1998 - 2002
PhD candidate in the laboratories of Professor Tony Barrett. Focus of research was development of macrolactonization protocols amenable to solid-phase synthesis of macrolides as well as development of other solid-phase methodologies. Funded by Norwegian Research Council